Argenx
OrganizationHeard in 13 episodes across 4 shows since Jun 2026
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. The company focuses on the development of antibody therapies for the treatment of autoimmune diseases and cancer, with a primary emphasis on orphan drugs.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Argenx per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 13 | 0.01‰ | 1 |
| Oct 16 | 0.03‰ | 2 |
| Oct 20 | 0.03‰ | 1 |
| Nov 6 | 0.01‰ | 1 |
| Nov 10 | 0.02‰ | 1 |
Email alert
Email me when Argenx comes up on a podcast
One email a week at most, with the new episodes that mention Argenx. Free, no account needed, unsubscribe in one click.
What experts have said about Argenx
5 statements · 5 positive
Argenx shares rose as much as 10%.
“shares up as much as 10%.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 2:45
Argenx's drug helps patients with an immune-system disease.
“this helps patients with an immune system disease.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 2:53
Argenx shares rose by as much as 10%.
“shares up as much as 10%.”
Open the episode · Fresnillo AstraZeneca Climbs, Argenx SurgesListen at 3:00
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
13 episodes featuring Argenx, newest first
- Nov 10, 2026
Midterms Put FDA Leadership and Drug Pricing in PlayBioCentury This WeekNov 10, 2026 - Nov 6, 2026
Election stakes meet biotech’s regulatory and pipeline risksBiotech HangoutNov 6, 2026 - Oct 20, 2026
China reshapes biotech deals as RNAi reaches the brainBioCentury This WeekOct 20, 2026 - Oct 16, 2026
Biotech selloff tests valuations as clinical bets advanceBiotech HangoutOct 16, 2026 - Oct 13, 2026
Biotech markets cool as trial failures test the sectorBioCentury This WeekOct 13, 2026 - Aug 17, 2026
Drug setbacks and copper demand reshape European stock movesStock MoversAug 17, 2026